Pacific Biosciences Of California ROA 2010-2024 | PACB
Current and historical return on assets (ROA) values for Pacific Biosciences Of California (PACB) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Pacific Biosciences Of California ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2024-06-30 | $-0.40B | $1.51B | -23.45% |
| 2024-03-31 | $-0.30B | $1.67B | -16.59% |
| 2023-12-31 | $-0.31B | $1.75B | -16.62% |
| 2023-09-30 | $-0.31B | $1.90B | -16.68% |
| 2023-06-30 | $-0.32B | $1.85B | -17.41% |
| 2023-03-31 | $-0.32B | $1.90B | -17.40% |
| 2022-12-31 | $-0.31B | $1.77B | -16.92% |
| 2022-09-30 | $-0.30B | $1.82B | -15.60% |
| 2022-06-30 | $-0.20B | $1.88B | -10.39% |
| 2022-03-31 | $-0.17B | $1.94B | -9.63% |
| 2021-12-31 | $-0.18B | $2.01B | -11.01% |
| 2021-09-30 | $-0.04B | $2.03B | -2.91% |
| 2021-06-30 | $-0.08B | $1.25B | -9.59% |
| 2021-03-31 | $-0.06B | $1.25B | -10.82% |
| 2020-12-31 | $0.03B | $0.41B | 9.97% |
| 2020-09-30 | $-0.05B | $0.30B | -20.51% |
| 2020-06-30 | $-0.05B | $0.21B | -27.46% |
| 2020-03-31 | $-0.05B | $0.24B | -30.29% |
| 2019-12-31 | $-0.08B | $0.15B | -51.61% |
| 2019-09-30 | $-0.12B | $0.15B | -68.35% |
| 2019-06-30 | $-0.11B | $0.17B | -62.54% |
| 2019-03-31 | $-0.11B | $0.19B | -64.50% |
| 2018-12-31 | $-0.10B | $0.17B | -63.68% |
| 2018-09-30 | $-0.09B | $0.18B | -59.90% |
| 2018-06-30 | $-0.09B | $0.14B | -60.40% |
| 2018-03-31 | $-0.09B | $0.16B | -58.40% |
| 2017-12-31 | $-0.09B | $0.14B | -60.39% |
| 2017-09-30 | $-0.09B | $0.16B | -59.67% |
| 2017-06-30 | $-0.09B | $0.18B | -57.05% |
| 2017-03-31 | $-0.08B | $0.14B | -53.24% |
| 2016-12-31 | $-0.07B | $0.14B | -49.49% |
| 2016-09-30 | $-0.06B | $0.15B | -37.74% |
| 2016-06-30 | $-0.04B | $0.16B | -27.07% |
| 2016-03-31 | $-0.03B | $0.14B | -25.64% |
| 2015-12-31 | $-0.03B | $0.13B | -28.57% |
| 2015-09-30 | $-0.05B | $0.10B | -45.90% |
| 2015-06-30 | $-0.06B | $0.10B | -53.45% |
| 2015-03-31 | $-0.07B | $0.11B | -55.83% |
| 2014-12-31 | $-0.07B | $0.12B | -51.26% |
| 2014-09-30 | $-0.06B | $0.12B | -48.58% |
| 2014-06-30 | $-0.08B | $0.13B | -53.76% |
| 2014-03-31 | $-0.08B | $0.14B | -53.90% |
| 2013-12-31 | $-0.08B | $0.14B | -55.42% |
| 2013-09-30 | $-0.08B | $0.15B | -59.61% |
| 2013-06-30 | $-0.09B | $0.13B | -62.32% |
| 2013-03-31 | $-0.09B | $0.14B | -59.86% |
| 2012-12-31 | $-0.10B | $0.13B | -59.10% |
| 2012-09-30 | $-0.10B | $0.15B | -52.53% |
| 2012-06-30 | $-0.10B | $0.17B | -49.70% |
| 2012-03-31 | $-0.10B | $0.20B | -44.74% |
| 2011-12-31 | $-0.11B | $0.22B | -43.78% |
| 2011-09-30 | $-0.12B | $0.24B | -45.02% |
| 2011-06-30 | $-0.13B | $0.26B | -54.92% |
| 2011-03-31 | $-0.15B | $0.28B | -81.12% |
| 2010-12-31 | $-0.14B | $0.31B | -128.44% |
| 2010-06-30 | $-0.09B | $0.00B | inf% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.668B | $0.201B |
| Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $212.628B | 25.94 |
| Intuitive Surgical (ISRG) | United States | $186.738B | 97.63 |
| Alcon (ALC) | Switzerland | $45.674B | 32.15 |
| IQVIA Holdings (IQV) | United States | $39.509B | 21.77 |
| Edwards Lifesciences (EW) | United States | $38.832B | 24.66 |
| IDEXX Laboratories (IDXX) | United States | $35.456B | 41.76 |
| DexCom (DXCM) | United States | $26.916B | 40.53 |
| Waters (WAT) | United States | $22.926B | 33.90 |
| SONOVA HOLDING (SONVY) | Switzerland | $21.977B | 0.00 |
| STERIS (STE) | Ireland | $21.252B | 24.49 |
| Hologic (HOLX) | United States | $18.417B | 19.43 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.517B | 12.85 |
| Sysmex ADR (SSMXY) | Japan | $12.405B | 38.90 |
| Globus Medical (GMED) | United States | $11.099B | 28.27 |
| Teleflex (TFX) | United States | $9.197B | 14.67 |
| Penumbra (PEN) | United States | $8.945B | 87.62 |
| Masimo (MASI) | United States | $8.639B | 41.80 |
| Glaukos (GKOS) | United States | $7.682B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $5.022B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.514B | 25.59 |
| Inari Medical (NARI) | United States | $3.035B | 0.00 |
| TransMedics (TMDX) | United States | $2.870B | 90.96 |
| Veracyte (VCYT) | United States | $2.868B | 86.84 |
| LivaNova (LIVN) | United Kingdom | $2.823B | 16.30 |
| Nihon Kohden (NHNKY) | Japan | $2.488B | 18.90 |
| Elekta AB (EKTAY) | Sweden | $2.336B | 19.03 |
| Tandem Diabetes Care (TNDM) | United States | $2.188B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.968B | 10.29 |
| RxSight (RXST) | United States | $1.881B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.334B | 0.00 |
| Artivion (AORT) | United States | $1.214B | 80.50 |
| Pulse Biosciences (PLSE) | United States | $1.106B | 0.00 |
| OPKO Health (OPK) | United States | $1.011B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.939B | 15.96 |
| IRadimed (IRMD) | United States | $0.707B | 38.23 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.696B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.666B | 0.00 |
| SiBone (SIBN) | United States | $0.649B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.638B | 15.10 |
| Paragon 28 (FNA) | United States | $0.591B | 0.00 |
| AxoGen (AXGN) | United States | $0.582B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.492B | 0.00 |
| CVRx (CVRX) | United States | $0.377B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.370B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.366B | 19.81 |
| Delcath Systems (DCTH) | United States | $0.304B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.291B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.276B | 18.50 |
| Sight Sciences (SGHT) | United States | $0.235B | 0.00 |
| Inogen (INGN) | United States | $0.224B | 0.00 |
| NeuroPace (NPCE) | United States | $0.221B | 0.00 |
| Accuray (ARAY) | United States | $0.210B | 0.00 |
| Nevro (NVRO) | United States | $0.199B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.189B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.156B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.129B | 0.00 |
| 908 Devices (MASS) | United States | $0.126B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.114B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.107B | 15.95 |
| EDAP TMS S.A (EDAP) | France | $0.101B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.090B | 0.00 |
| LENSAR (LNSR) | United States | $0.080B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.079B | 0.00 |
| Hyperfine (HYPR) | United States | $0.070B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.068B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.062B | 0.00 |
| InspireMD (NSPR) | Israel | $0.059B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.054B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.053B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.047B | 0.00 |
| Envoy Medical (COCH) | United States | $0.040B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.036B | 0.00 |
| Neuronetics (STIM) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.029B | 0.00 |
| Precision Optics (POCI) | United States | $0.029B | 0.00 |
| Spectral AI (MDAI) | United States | $0.025B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.020B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.014B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.014B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.012B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.010B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |